​

Akoya Biosciences (AKYA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Akoya Biosciences Revenue Highlights

Latest Revenue (Y)

$81.67M

Latest Revenue (Q)

$18.81M

Main Segment (Y)

Product

Main Geography (Y)

North America

Akoya Biosciences Revenue by Period

Akoya Biosciences Revenue by Year

DateRevenueChange
2024-12-31$81.67M-15.48%
2023-12-31$96.63M29.09%
2022-12-31$74.86M36.31%
2021-12-31$54.92M29.39%
2020-12-31$42.44M0.49%
2019-12-31$42.24M-

Akoya Biosciences generated $81.67M in revenue during NA 2024, up -15.48% compared to the previous quarter, and up 193.37% compared to the same period a year ago.

Akoya Biosciences Revenue by Quarter

DateRevenueChange
2024-09-30$18.81M-18.78%
2024-06-30$23.16M26.23%
2024-03-31$18.35M-30.72%
2023-12-31$26.49M5.04%
2023-09-30$25.21M7.20%
2023-06-30$23.52M9.86%
2023-03-31$21.41M0.90%
2022-12-31$21.22M12.56%
2022-09-30$18.85M5.35%
2022-06-30$17.89M5.92%
2022-03-31$16.89M4.56%
2021-12-31$16.16M19.90%
2021-09-30$13.48M3.10%
2021-06-30$13.07M7.03%
2021-03-31$12.21M-5.39%
2020-12-31$12.91M29.68%
2020-09-30$9.95M16.29%
2020-06-30$8.56M-22.33%
2020-03-31$11.02M-

Akoya Biosciences generated $18.81M in revenue during Q3 2024, up -18.78% compared to the previous quarter, and up 79.99% compared to the same period a year ago.

Akoya Biosciences Revenue Breakdown

Akoya Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21
Consumables$28.26M$24.13M$18.38M$14.30M
Service and other$28.64M$29.22M$17.21M$10.44M
Product$53.03M$67.41M$57.65M$44.48M
Standalone software products$940.00K$1.18M$636.00K$1.49M
Service And Other$17.28M$18.93M--
Instruments$23.83M$42.09M$38.63M$28.69M

Akoya Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (34.89%), Service and other (18.85%), Consumables (18.59%), Instruments (15.68%), Service And Other (11.37%), and Standalone software products (0.62%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Instruments$13.22M$5.74M$4.87M$21.21M$11.28M$9.61M$11.14M$9.51M$9.46M$8.52M$8.50M$7.10M$6.26M$6.84M
Service And Other$10.17M$3.73M$3.38M-----------
Standalone software products$402.00K$268.00K$270.00K$924.00K$52.00K$205.00K$39.00K$200.00K$203.00K$194.00K$409.00K---
Service and other$15.92M$6.52M$6.21M$16.96M$6.37M$5.89M$5.51M$4.41M$3.73M$3.55M$3.24M---
Product$28.59M$12.30M$12.14M$34.74M$17.15M$15.52M$15.71M$14.44M$14.16M$13.34M$12.92M$10.87M$10.72M$9.96M
Consumables$14.96M$6.29M$7.00M$12.60M$5.82M$5.71M$4.53M$4.72M$4.50M$4.63M$4.01M$3.43M$4.31M$2.54M
Service-----------$2.60M$2.35M$2.25M
Standalone Software Products-----------$345.00K$151.00K$582.00K

Akoya Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product (34.33%), Service and other (19.12%), Consumables (17.97%), Instruments (15.88%), Service And Other (12.21%), and Standalone software products (0.48%).

Akoya Biosciences Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 23Dec 22Dec 21
APAC$11.96M$16.55M$15.06M$12.53M
North America$50.86M$58.28M$42.05M$28.03M
EMEA$18.85M$21.80M$17.75M$14.36M

Akoya Biosciences's latest annual revenue breakdown by geography, as of Dec 24: North America (62.27%), EMEA (23.08%), and APAC (14.65%).

Quarterly Revenue by Country

CountryDec 24Sep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
APAC$5.66M$3.03M$3.27M$8.06M$4.11M$4.39M$3.47M$3.81M$4.27M$3.51M$3.00M---
North America$30.15M$10.59M$10.12M$32.62M$13.81M$11.85M$12.32M$10.92M$9.48M$9.32M$9.02M$7.39M$6.40M$5.21M
EMEA$8.70M$5.19M$4.96M$11.02M$5.60M$5.17M$5.43M$4.12M$4.14M$4.06M$4.13M---
E M E A-----------$3.25M$3.66M$3.31M
Asia Pacific-----------$2.83M$3.01M$3.69M

Akoya Biosciences's latest quarterly revenue breakdown by geography, as of Dec 24: North America (67.73%), EMEA (19.54%), and APAC (12.72%).

Akoya Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
COOCooper Companies$3.90B$964.70M
ATRAptarGroup$3.58B$909.29M
ICUIICU Medical$2.38B$589.13M
HAEHaemonetics$1.31B$348.54M
ATRCAtriCure$465.31M$115.91M
ANGOAngioDynamics$303.91M$72.00M
LMATLeMaitre Vascular$219.86M$54.82M
AKYAAkoya Biosciences$81.67M$18.81M
PDEXPro-Dex$53.84M$16.79M
UTMDUtah Medical Products$40.90M$10.01M

AKYA Revenue FAQ

What is Akoya Biosciences’s yearly revenue?

Akoya Biosciences's yearly revenue for 2024 was $81.67M, representing a decrease of -15.48% compared to 2023. The company's yearly revenue for 2023 was $96.63M, representing an increase of 29.09% compared to 2022. AKYA's yearly revenue for 2022 was $74.86M, representing an increase of 36.31% compared to 2021.

What is Akoya Biosciences’s quarterly revenue?

Akoya Biosciences's quarterly revenue for Q3 2024 was $18.81M, a -18.78% decrease from the previous quarter (Q2 2024), and a -25.39% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $23.16M, a 26.23% increase from the previous quarter (Q1 2024), and a -1.52% decrease year-over-year (Q2 2023). AKYA's quarterly revenue for Q1 2024 was $18.35M, a -30.72% decrease from the previous quarter (Q4 2023), and a -14.29% decrease year-over-year (Q1 2023).

What is Akoya Biosciences’s revenue growth rate?

Akoya Biosciences's revenue growth rate for the last 3 years (2022-2024) was 9.10%, and for the last 5 years (2020-2024) was 92.43%.

What are Akoya Biosciences’s revenue streams?

Akoya Biosciences's revenue streams in c 24 are Consumables, Service and other, Product, Standalone software products, Service And Other, and Instruments. Consumables generated $28.26M in revenue, accounting 18.59% of the company's total revenue, up 17.09% year-over-year. Service and other generated $28.64M in revenue, accounting 18.85% of the company's total revenue, down -1.98% year-over-year. Product generated $53.03M in revenue, accounting 34.89% of the company's total revenue, down -21.34% year-over-year. Standalone software products generated $940K in revenue, accounting 0.62% of the company's total revenue, down -20.41% year-over-year. Service And Other generated $17.28M in revenue, accounting 11.37% of the company's total revenue, down -8.73% year-over-year. Instruments generated $23.83M in revenue, accounting 15.68% of the company's total revenue, down -43.39% year-over-year.

What is Akoya Biosciences’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Akoya Biosciences was Product. This segment made a revenue of $53.03M, representing 34.89% of the company's total revenue.